 treatment fulmin viral hepat failur prostaglandin preliminari report effect prostaglandin PG patient fulmin subfulmin viral hepat seventeen patient fhf secondari hepat non-a non-b nanb hepat patient stage iii IV hepat encephalopathi HE present mean ast units/lit bilirubin mumol/lit PT ptt sec coagul factor vii twelv patient decreas ast units/lit decreas prothrombin time sec sec ptt sec sec increas factor factor vii respond nanb hepat discontinu therapi recurr HE ast PT improv retreat week intraven therapi oral patient remiss month cessat therapi addit patient remiss month relaps patient hepat viru hav hepat viru hbv infect liver biopsi patient normal result efficaci pge fhf further investig